ask="5.20"
ask_size="1600"
average_daily_volume="315723"
bid="4.21"
bid_size="11000"
book_value="0.74"
change="-0.35"
change_from_200_day_moving_average="1.74"
change_from_50_day_moving_average="1.16"
change_from_52_week_high="-0.98"
change_From_52_week_low="3.23"
change_in_percent="-6.93%"
close="4.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-1.18"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.87"
high_52_weeks="5.68"
last_trade_date="3/14/2017"
last_trade_price="4.70"
last_trade_size="3362"
last_trade_time="4:00pm"
low="4.50"
low_52_weeks="1.47"
market_capitalization="160.50M"
moving_average_200_day="2.96"
moving_average_50_day="3.54"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.80"
open="4.82"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+58.99%"
percent_change_from_50_day_moving_average="+32.92%"
percent_change_from_52_week_high="-17.25%"
percent_change_from_52_week_low="+219.73%"
previous_close="5.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.80"
price_per_sales="38.74"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="2.29"
stock_exchange="NGM"
symbol="FATE"
volume="640640"
weeks_range_52="1.47 - 5.68"
